IL-4对CD180表达和信号在慢性淋巴细胞白血病 (CLL) 的影响

Ani Bilanishvili1, Tamar Tsertsvadze2, Kurtis Edwards3

  • 1Ivane Javakhishvili Tbilisi State University, Faculty of Exact and Natural Sciences, Division of Immunology and Microbiology, Tbilisi, Georgia.

Leukemia research
|January 17, 2026
PubMed
概括

互白素-4 (IL-4) 增强了Toll类受体CD180在慢性淋巴细胞白血病 (CLL) 细胞上的表达. 这种相互作用通过激活AKT和p38MAPK等关键信号通路来影响CLL细胞的存活和增殖.